Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review: Études Pharmacogénomiques en Déficiences Intellectuelles et Trouble du Spectre de L'autisme: Une Revue Systématique.

Kazunari YoshidaEmiko KoyamaClement C ZaiJoseph H BeitchmanJames L KennedyYona LunskyPushpal DesarkarDaniel J Müller

Published in: Canadian journal of psychiatry. Revue canadienne de psychiatrie (2020)

There is limited data available on PGx in individuals with ASD/ID and in particular in adults. Given the potential for PGx testing in improving treatment outcomes, additional PGx studies for psychotropic treatment in ASD/ID across age groups are warranted.

Keyphrases

autism spectrum disorder
attention deficit hyperactivity disorder
intellectual disability
case control
electronic health record
big data
clinical decision support
machine learning
human health
artificial intelligence
combination therapy
replacement therapy